Related Experiment Video

Updated: Nov 7, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K

Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?

Karen Manoutcharian1, Jesus Guzman Valle2, Goar Gevorkian2

  • 1Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70228, Ciudad Universitaria, 04510, Mexico, DF, Mexico. karman@unam.mx.

Archivum Immunologiae Et Therapiae Experimentalis
|April 28, 2021
PubMed

Insights

Neoantigen cancer vaccines face challenges due to evolving mutations. A novel Variable Epitope Libraries approach aims to overcome immune escape for broader vaccine efficacy.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Neoantigen cancer vaccines are personalized but face challenges.
  • The evolving mutational landscape of cancer impacts vaccine effectiveness.
  • Similarities exist between cancer and antigenically variable pathogens.

Purpose of the Study:

  • Analyze factors and immunological phenomena in neoantigen cancer vaccines.
  • Evaluate the efficacy of neoantigens as vaccine targets.
  • Introduce and assess a novel vaccine platform for cancer immunotherapy.

Main Methods:

  • Review of Phase I clinical trials for neoantigen cancer vaccines.
  • Analysis of immunological responses to neoantigens.
  • Development and conceptualization of Variable Epitope Libraries.

Main Results:

  • Identified obstacles in the current neoantigen vaccine paradigm.
  • Highlighted the need for vaccines that induce diverse immune cell pools to prevent immune escape.
  • Proposed Variable Epitope Libraries as a universal vaccine platform.

Conclusions:

  • Personalized neoantigen vaccines face significant challenges regarding clinical relevance.
  • The Variable Epitope Libraries concept offers a potential strategy to address antigenic variability in cancer.
  • Further research is needed to define the prospective clinical utility of these novel vaccine approaches.
Keywords:
Immune escapeNeoantigen cancer vaccineVariable epitope library

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.8K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.0K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
603
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
807
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Vaccinations01:51

Vaccinations

Overview
48.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K